Stop playing with data: there is no sound evidence that Bacille Calmette-Guérin may avoid SARS-CoV-2 infection (for now).
Open Access
- 11 May 2020
- journal article
- review article
- Vol. 91 (2) , 207-213
Abstract
Since the beginning of the COVID-19 epidemic, a possible explanation for the high heterogeneity of infection/mortality rates across involved countries was hinted in the prevalence of tuberculosis vaccination with Bacille Calmette-Guérin (BCG). A systematic review was therefore performed on May 2, 2020. A total of 13 articles were ultimately retrieved, 12 of them as preprint papers. All articles were ecological studies of low quality. Most of them did not include main confounding factors (i.e. demographic of the assessed countries, share of peo- ple residing in urban settings, etc.), and simply assessed the differences among incidence/mortality of COVID-19 with vaccination rates or by having vs. having not any vaccination policy for BCG. Even though all studies shared the very same information sources (i.e. international registries for BCG vaccination rates and open source data for COVID-19 epidemics), results were conflicting, with later studies apparently denying any true correlation between COVID-19 occurrence and BCG vaccination rates and/or policies. As a consequence, there is no sound evidence to recommend BCG vaccination for the prevention of COVID-19.Keywords
This publication has 18 references indexed in Scilit:
- COVID-19 in Italy: impact of containment measures and prevalence estimates of infection in the general population2020
- Protecting healthcare workers from SARS-CoV-2 infection: practical indicationsEuropean Respiratory Review, 2020
- Non-specific effects of BCG vaccine on viral infectionsClinical Microbiology and Infection, 2019
- The global tuberculosis epidemic and progress in care, prevention, and research: an overview in year 3 of the End TB eraThe Lancet Respiratory Medicine, 2018
- Vaccine coverage in Italy and assessment of the 2012-2014 National Immunization Prevention Plan.2015
- BCG Vaccination Enhances the Immunogenicity of Subsequent Influenza Vaccination in Healthy Volunteers: A Randomized, Placebo-Controlled Pilot StudyThe Journal of Infectious Diseases, 2015
- Prevalence of latent tuberculosis infection in BCG-vaccinated healthcare workers by using an interferon-gamma release assay and the tuberculin skin test in an intermediate tuberculosis burden countryJournal of Microbiology, Immunology and Infection, 2015
- The efficacy of Bacillus Calmette-Guerin vaccinations for the prevention of acute upper respiratory tract infection in the elderly.2011
- Epidemiology of tuberculosis in a low-incidence Italian region with high immigration rates: differences between not Italy-born and Italy-born TB casesBMC Public Health, 2011
- Acute lower respiratory tract infections and respiratory syncytial virus in infants in Guinea-Bissau: a beneficial effect of BCG vaccination for girlsVaccine, 2005